Investigational New Drugs
Last updated ISSN 0167-6997
Investigational New Drugs is published by Springer Science+Business Media in medicine. It is a subscription journal. The article processing charge is $4,690.
Is your paper a fit?
The surest way to know is to compare your own abstract against what this journal has actually been publishing, rather than against its aims-and-scope page. Paste your abstract and Journal Hunt will tell you how close Investigational New Drugs is — and show you journals like it.
What it publishes
Recent work in Investigational New Drugs concentrates on these topics, taken from its published record rather than from its own description:
- Cancer Treatment and Pharmacology
- Cancer therapeutics and mechanisms
- Lung Cancer Treatments and Mutations
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
- Pancreatic and Hepatic Oncology Research
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- PI3K/AKT/mTOR signaling in cancer
- Chronic Lymphocytic Leukemia Research
Key facts
| Publisher | Springer Science+Business Media |
|---|---|
| ISSN | 0167-6997, 1573-0646 |
| Subject area | Medicine |
| Access | Subscription |
| Article processing charge | $4,690 |
| Indexed in | Web of Science — Science Citation Index Expanded · Scopus |
| Articles published | 3,982 |
| Publishing since | 1801 |
| Journal website | www.springer.com/journal/10637 |
Facts come from OpenAlex, DOAJ and Wikidata and may lag the journal’s own pages. Check the publisher’s site before submitting. Indexing shown here is what is recorded, not a complete picture — about a third of journals have no indexing recorded anywhere we can read, so “not recorded” does not mean a journal is absent from Scopus or Web of Science.
Journals like Investigational New Drugs
Other established journals in medicine, if this one is not the right home for your paper: